Medical devices, healthcare technology and the business of care
510(k) clearance · K260879

4DM

INVIA, LLC · Decision date Sep 10, 2026

MEDTECHLEDGER EXPLANATIONK260879

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for 4DM, a software application from INVIA, LLC, on September 10, 2026, under 510(k) number K260879. The device is regulated as a medical image management and processing system under 21 CFR 892.2050, Class II, with product codes QIH and LLZ, in the radiology specialty. A 510(k) clearance is not a PMA approval.

The submission describes 4DM as software as a medical device for image review and clinical reporting of nuclear medicine, PET, CT, MR and hybrid studies, and states it does not provide diagnoses or therapeutic recommendations. The summary names Corridor4DM (K101279) as the predicate and Cvi42 (K242781) as a reference device, describing 4DM as an updated version of the predicate. The summary lists deep-learning features for cardiac isolation from CT and for volumetric blood flow images. The source does not include performance testing results or the specific changes from the predicate.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 10, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260879
Regulatory pathway
510(k) premarket notification
Applicant
INVIA, LLC
Product code
QIH
Decision code
SESE
Decision date
Sep 10, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated Radiological Image Processing Software.

Applicant
INVIA, LLC
Product code
QIH
FDA device class
2

FDA decision timeline

  1. K260879 received

    Application receipt date recorded by FDA.

  2. K260879 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QIH

Product / regulatory recordCompanyPathwayDecision dateSource
Clever OneK260372
Ewoosoft Co., Ltd.510(k) clearanceNov 4, 2026FDA
Peek Health, S.A.510(k) clearanceNov 4, 2026FDA
AVICENNA.AI510(k) clearanceOct 19, 2026FDA
UAB Ligence510(k) clearanceOct 7, 2026FDA
NeuroDRK262134
Deep Reasoning Ai, Inc.510(k) clearanceOct 7, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

INVIA, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Ann Arbor, MI

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records